 |
Amryt Pharma plc
AMYT
|
$ 14.7 |
- |
$ 621 M |
Nasdaq Global Select Market |
Britain |
 |
Aerie Pharmaceuticals
AERI
|
$ 15.25 |
- |
$ 754 M |
Nasdaq Global Market,SPB |
USA |
 |
PetIQ
PETQ
|
$ 13.6 |
1.64 % |
$ 400 M |
Nasdaq Global Select Market,SPB |
USA |
 |
Agile Therapeutics
AGRX
|
$ 0.6 |
10.11 % |
$ 58.2 M |
Nasdaq Capital Market |
USA |
 |
Teligent, Inc.
TLGT
|
$ 0.173 |
-13.85 % |
$ 16.1 M |
Nasdaq Global Select Market |
USA |
 |
Recro Pharma
REPH
|
$ 1.4 |
-4.76 % |
$ 65.3 M |
Nasdaq Global Select Market |
USA |
 |
Athenex
ATNX
|
$ 0.2 |
-23.39 % |
$ 1.76 M |
Nasdaq Global Select Market |
USA |
 |
Solid Biosciences
SLDB
|
$ 5.53 |
-3.99 % |
$ 110 M |
Nasdaq Global Select Market,SPB |
USA |
 |
ANI Pharmaceuticals
ANIP
|
$ 61.63 |
3.27 % |
$ 1.19 B |
Nasdaq Global Market,SPB |
USA |
 |
PLx Pharma
PLXP
|
$ 0.09 |
-27.8 % |
$ 2.56 M |
Nasdaq Capital Market |
USA |
 |
Phibro Animal Health Corporation
PAHC
|
$ 23.31 |
-0.85 % |
$ 944 M |
Nasdaq Global Market,SPB |
USA |
 |
Amphastar Pharmaceuticals
AMPH
|
$ 28.21 |
0.55 % |
$ 1.37 B |
Nasdaq Global Select Market |
USA |
 |
Pacira BioSciences
PCRX
|
$ 23.73 |
0.91 % |
$ 1.1 B |
Nasdaq Global Select Market,SPB |
USA |
 |
Lannett Company
LCI
|
$ 0.66 |
1.15 % |
$ 7.11 M |
NYSE |
USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
$ 40.0 |
-0.1 % |
$ 2.03 B |
Nasdaq Global Select Market |
Schweden |
 |
GW Pharmaceuticals plc
GWPH
|
$ 218.96 |
- |
$ 6.81 B |
Nasdaq Global Select Market |
Britain |
 |
Adamas Pharmaceuticals, Inc.
ADMS
|
$ 8.22 |
- |
$ 376 M |
Nasdaq Global Market |
USA |
 |
Flexion Therapeutics, Inc.
FLXN
|
$ 9.12 |
- |
$ 459 M |
Nasdaq Global Market |
USA |
 |
Happiness Biotech Group Limited
HAPP
|
$ 4.5 |
1.35 % |
$ 17.8 M |
Nasdaq Capital Market |
China |